VII Report Health Search Page 239

APPENDICE 3

P UBBLICAZIONI SU RIVISTE

INDICIZZATE SU PUBMED

Schuemie MJ, Coloma PM, Straatman H, Herings RM, Trifirò G, Matthews JN,Prieto-Meri-
no D, Molokhia M, Pedersen L, Gini R, Innocenti F, Mazzaglia G,Picelli G, Scotti L, van der
Lei J, Sturkenboom MC. Using Electronic Health Care Records for Drug Safety Signal
Detection: A Comparative Evaluation of Statistical Methods. Med Care. 2012 Aug
26.

Valkhoff VE, van Soest EM, Masclee GM, de Bie S, Mazzaglia G, Molokhia M,Kuipers EJ,
Sturkenboom MC. Prescription of nonselective NSAIDs, coxibs and gastroprotecti-
ve agents in the era of rofecoxib withdrawal - a 617 400-patient study. Aliment
Pharmacol Ther. 2012 Aug 28.

Aguglia E, Ravasio R, Simonetti M, Pecchioli S, Mazzoleni F. Use and treatment moda-
lities for SSRI and SNRI antidepressants in Italy during the period 2003-2009. Curr
Med Res Opin. 2012 Jul 19.

Trifirò G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M,Bianchini E, Medea
G, Cricelli C, Caputi AP, Mazzaglia G. Epidemiology of gout and hyperuricaemia
in Italy during the years 2005-2009: a nationwide population-based study. Ann
Rheum Dis. 2012 Jun 26.

Valkhoff VE, van Soest EM, Mazzaglia G, Molokhia M, Schade R, Trifiro G,Goldstein JL,
Hernandez-Diaz S, Kuipers EJ, Sturkenboom MC. Adherence to gastroprotection du-
ring cyclooxygenase 2 inhibitor treatment and therisk of upper gastrointestinal
tract events: A population-based study. Arthritis Rheum. 2012 Aug;64(8):2792-802.

Coloma PM, Trifirò G, Schuemie MJ, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Picelli
G, Corrao G, Pedersen L, van der Lei J, Sturkenboom M; EU-ADR Consortium. Electronic
healthcare databases for active drug safety surveillance: is there enough levera-
ge? Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):611-21.

Trifirò G, Mokhles MM, Dieleman JP, van Soest EM, Verhamme K, Mazzaglia G, Herings R,
de Luise C, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, van Camp G, Zanettini
R, Sturkenboom MC. Risk of cardiac valve regurgitation with dopamine agonist
use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-
control study. Drug Saf. 2012 Feb 1;35(2):159-71.

Mokhles MM, Trifirò G, Dieleman JP, Haag MD, van Soest EM, Verhamme KM,Mazzaglia
G, Herings R, Luise Cd, Ross D, Brusselle G, Colao A, Haverkamp W,Schade R, Camp Gv,
Zanettini R, Sturkenboom MC. The risk of new onset heart failure associated with
dopamine agonist use in Parkinson's disease. PharmacolRes. 2012 Mar;65(3):358-64.

Lapi F, Simonetti M, Michieli R, Pasqua A, Brandi ML, Frediani B, Cricelli C, Mazzaglia G.
Assessing 5-year incidence rates and determinants of osteoporotic fractures in
primary care. Bone. 2012 Jan;50(1):85-90.

10. Cazzola M, Calzetta L, Bettoncelli G, Cricelli C, Romeo F, Matera MG,RoglianiP. Cardio-

vascular disease in asthma and COPD: a population-based retrospective cross-
sectional study. Respir Med. 2012 Feb;106(2):249-56.

11. van Soest EM, Valkhoff VE, Mazzaglia G, Schade R, Molokhia M, Goldstein JL, Hernández-

Díaz S, Trifirò G, Dieleman JP, Kuipers EJ, Sturkenboom MC. Suboptimal gastropro-
tective coverage of NSAID use and the risk of upper gastrointestinal bleeding
and ulcers: an observational study using three European databases. Gut. 2011
Dec;60(12):1650-9. Epub 2011 Jun 2.